SCHEDULE: Pure Raw Supplies LLC Acquires 100% of Nutra Pharma Series B Shares

Pure Raw Supplies LLC reports acquiring 100% of Nutra Pharma Corp's Series B Preferred Shares via a gift, holding them for investment purposes.

Summary

• Pure Raw Supplies, LLC, a Florida-based entity, has reported acquiring 100% of Nutra Pharma Corp's Series B Preferred Shares.
• The acquisition occurred on August 21, 2026, through a bona fide gift from Rik Deitsch.
• No funds were borrowed or consideration paid for this acquisition.
• The reporting person, Pure Raw Supplies, LLC, intends to hold these shares for investment purposes.
• There are no current plans or proposals that would lead to significant changes in the company's operations or structure.
• Elizabeth Deitsch, President of Pure Raw Supplies, LLC, certified the accuracy of the filing.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the lack of operational or financial updates and the focus on a change in beneficial ownership via a gift, which does not inherently signal company performance.

Positives

• Pure Raw Supplies, LLC now holds 100% of the Series B Preferred Shares, consolidating ownership.
• The acquisition was a gift, meaning no debt was incurred by Pure Raw Supplies, LLC for this transaction.

Negatives

• The filing does not provide any operational or financial performance updates for Nutra Pharma Corp.
• The primary event is a change in beneficial ownership through a gift, which does not indicate business growth or improvement.

Risks

• The filing does not disclose any specific risks related to Nutra Pharma Corp's business operations or financial health.
• Potential future actions by the new controlling shareholder (Pure Raw Supplies, LLC) are not detailed, leaving uncertainty about strategic direction.

Future Outlook

The filing states that the reporting person holds the shares for investment purposes and currently has no plans or proposals that relate to or would result in any of the actions described in clauses (a) through (j) of Item 4 of Schedule 13D. This indicates a lack of immediate strategic initiatives from the new beneficial owner.

Management Comments

• "The Reporting Person acquired the Shares pursuant to a bona fide gift and not as part of any purchase transaction."
• "The Reporting Person holds the Shares for investment purposes."
• "The Reporting Person does not presently have any plans or proposals that relate to or would result in any of the actions described in clauses (a) through (j) of Item 4 of Schedule 13D."

Industry Context

StockSavvy.ai notes that this filing is a Schedule 13D, which typically signals a significant change in beneficial ownership. However, in this case, the change is due to a gift, and the reporting entity has no immediate plans for the company, suggesting this is more of a structural ownership update rather than a strategic move impacting the pharmaceutical sector.

Related Party Transactions

• The acquisition of Series B Preferred Shares by Pure Raw Supplies, LLC from Rik Deitsch was a bona fide gift.

Stakeholder Impact

• Shareholders: The change in beneficial ownership to 100% of Series B Preferred Shares by Pure Raw Supplies, LLC may lead to future strategic decisions, but no immediate impact is indicated.
• Management: No direct impact on current management is stated, but a significant shift in ownership could influence future board composition or strategic direction.

Next Steps

• Pure Raw Supplies, LLC will continue to hold the Series B Preferred Shares for investment purposes.
• No immediate plans for actions related to the issuer's business or structure are disclosed.

Key Dates

Keywords

Series B Preferred Shares, Beneficial Ownership, Nutra Pharma Corp, Pure Raw Supplies LLC, Gift Acquisition, Investment Purposes, Schedule 13D